Health Care: Drugs

Alnylam Pharmaceuticals Inc (ALNY: NASDAQ)

$53.6 n/a | n/a%
04/28/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 47.16M 41.10M 50.56M 47.17M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 47.16M 41.10M 50.56M 47.17M
Selling, General, and Administrative Expenses 89.35M 60.61M 44.53M 27.15M
Research & Development 382.39M 276.50M 411.01M 112.96M
Operating Income before D & A (EBITDA) -424.59M -296.01M -404.98M -92.94M
Depreciation & Amortization 15.13M 19.05M 11.93M 10.23M
Interest Income 8.31M 5.86M 2.56M 1.07M
Other Income - Net 6.17M 76.00K 1.82M -47.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -425.24M -309.12M -412.53M -102.15M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -425.24M -309.12M -412.53M -102.15M
Income Taxes 0.00 0.00 -40.21M -2.69M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -410.11M -290.07M -360.39M -89.22M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -410.11M -290.07M -360.39M -89.22M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -410.11M -290.07M -360.39M -89.22M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-410.11M -290.07M -360.39M -89.22M
Preferred Dividends
Net Income Available To Common -410.11M -290.07M -360.39M -89.22M
Basic EPS from Continuing Ops. -4.79 -3.45 -4.85 -1.45
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -4.79 -3.45 -4.85 -1.45
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -4.79 -3.45 -4.85 -1.45
Basic Normalized Net Income/Share -4.79 -3.45 -4.85 -1.45
EPS fr Continuing Ops. -4.79 -3.45 -4.85 -1.45
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -4.79 -3.45 -4.85 -1.45
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -4.79 -3.45 -4.85 -1.45
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-4.79 -3.45 -4.85 -1.45
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ALNY

Latest ALNY Headlines from TheStreet

More Financial News for ALNY

Press Releases for ALNY

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter